Skip navigation
Home
Browse
Help
???jsp.layout.navbar-default.datos1???
INSP Repositorio
Página de inicio
Listar
Comunidades
Buscar elementos por:
Fecha Publicación
Autor
Título
Materia
Contacto
Políticas de Privacidad
English
Español
DSpace
JSPUI
DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets
Learn More
INSP
Alertas
Editar Perfil
DSpace - INSP
Browsing by Subject
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Showing results 432 to 451 of 1355
< previous
next >
anti HBc;VIH, anti HCV; México
1
Anti-Bacterial Agents / pharmacology Bacteremia / epidemiology Bacteremia / etiology Bacteremia / microbiology Carbapenem-Resistant Enterobacteriaceae / drug effects Carbapenem-Resistant Enterobacteriaceae / genetics Carbapenem-Resistant Enterobacteriaceae / isolation & purification Carbapenem-Resistant Enterobacteriaceae / metabolism Child Disease Outbreaks* Enterobacteriaceae / drug effects Enterobacteriaceae / genetics Enterobacteriaceae / isolation & purification Enterobacteriaceae / metabolism* Enterobacteriaceae Infections / epidemiology Enterobacteriaceae Infections / etiology* Enterobacteriaceae Infections / microbiology Genome, Bacterial / genetics Hospitals Humans Mexico / epidemiology Microbial Sensitivity Tests Multilocus Sequence Typing Parenteral Nutrition, Total / adverse effects* Phylogeny beta-Lactamases / genetics beta-Lactamases / metabolism* nan
1
Anti-Bacterial Agents / pharmacology* Anti-Bacterial Agents / therapeutic use Bacterial Proteins / genetics Carbapenems / pharmacology* Carbapenems / therapeutic use Genes, Bacterial Genotype Gram-Negative Bacteria / drug effects* Gram-Negative Bacteria / enzymology Gram-Negative Bacteria / genetics Gram-Negative Bacteria / isolation & purification Gram-Negative Bacterial Infections / diagnosis Gram-Negative Bacterial Infections / drug therapy* Gram-Negative Bacterial Infections / epidemiology Gram-Negative Bacterial Infections / microbiology Humans Mexico / epidemiology Microbial Sensitivity Tests Phenotype beta-Lactam Resistance / genetics* beta-Lactamases / genetics nan
1
Anti-Bacterial Agents* / therapeutic use Hospitals, Public* Humans Mexico / epidemiology Pilot Projects Prevalence Reproducibility of Results World Health Organization nan
1
Anti-HIV Agents / economics Anti-HIV Agents / therapeutic use Costs and Cost Analysis* Female HIV / isolation & purification HIV Infections / diagnosis HIV Infections / drug therapy HIV Infections / economics HIV Infections / transmission* Health Facilities / economics* Humans Infant Infectious Disease Transmission, Vertical / economics* Infectious Disease Transmission, Vertical / prevention & control* Mass Screening / economics* Pregnancy Prenatal Care / economics* Zimbabwe nan
1
Antibiotics, Mexico, Over the counter sales, Antibiotic resistance, Media analysis, Pharmaceutical policy
1
antibióticos, resistencia antimicrobiana
1
Antibodies, Protozoan Antigens, Protozoan Case-Control Studies Chagas Disease* / diagnosis Chagas Disease* / drug therapy Chronic Disease Humans Retrospective Studies Trypanosoma cruzi* / immunology nan
1
Antibodies, Viral COVID-19* Coronavirus 229E, Human* Cross-Sectional Studies Female Humans SARS-CoV-2 Substances nan
1
Antibodies, Viral biosynthesisAntibodies, Viral bloodChildFemaleHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 administration dosage,Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 immunologyHuman papillomavirus 16 immunologyHuman papillomavirus 18 immunologyHumansImmunization Schedule,Immunization, Secondary methodsImmunogenicity, Vaccine immunologyMexicoTime Factors,HPV vaccine, alternative vaccination schedules immunization immunogenicity secondary vaccine.
1
Antibodies, Viral blood,Child, PreschoolCross-Sectional StudiesFemaleHumansImmunization ScheduleInfantMaleMexico epidemiologyNutrition SurveysPoliomyelitis epidemiology,Poliomyelitis prevention controlPoliomyelitis virologyPoliovirus immunologyPoliovirus Vaccine, Inactivated immunologyPoliovirus Vaccine, Oral immunologySeroepidemiologic StudiesVaccination,SD
1
Antibodies, Viral / blood Asymptomatic Diseases Betacoronavirus* / immunology COVID-19 COVID-19 Testing Clinical Laboratory Techniques Computer Systems Contact Tracing Coronavirus Infections / diagnosis Coronavirus Infections / epidemiology* Coronavirus Infections / prevention control Developing Countries Epidemiological Monitoring* Global Health Health Policy Humans Income Intersectoral Collaboration* Mexico / epidemiology Pandemics* / prevention control Pneumonia, Viral / diagnosis Pneumonia, Viral / epidemiology* Pneumonia, Viral / prevention control Population Surveillance Practice Guidelines as Topic Public Health* Quarantine SARS-CoV-2 Seroepidemiologic Studies Telemedicine World Health Organization
1
Antibodies, Viral; Argentina; Brazil; COVID-19 / diagnosis; COVID-19 / immunology; COVID-19 / prevention & control; COVID-19 Serological Testing; COVID-19 Vaccines / immunology; Chile; Colombia; Health Policy; Humans; Immunization / standards; Latin America; Mexico; Pandemics; SARS-CoV-2; Vaccination COVID-19; Latin America; SARS-CoV-2; antibody tests; diagnostic tests; health policy; immunization; pandemic; serology tests; vaccination.
1
Antigens, Protozoan / genetics* Antigens, Protozoan / immunology Cysteine / genetics Epitopes, B-Lymphocyte / genetics Epitopes, B-Lymphocyte / immunology Exons / genetics Host-Parasite Interactions / genetics Host-Parasite Interactions / immunology Humans Malaria, Vivax / immunology Malaria, Vivax / parasitology Mutation Plasmodium vivax / genetics* Plasmodium vivax / immunology Plasmodium vivax / pathogenicity Polymorphism, Genetic / immunology Protozoan Proteins / genetics* Protozoan Proteins / immunology Recombination, Genetic / immunology* Selection, Genetic / immunology* Sequence Analysis, DNA nan
1
Antimicrobial, Essential Oil, Escherichia coli, Bacteria, Activity
1
Antineoplastic Agents / economics* Antineoplastic Agents / supply & distribution* Commerce / statistics & numerical data Costs and Cost Analysis / statistics & numerical data Drugs, Essential / economics* Drugs, Essential / supply & distribution* Hospitals, Public Humans Mexico Neoplasms / drug therapy* Pharmacies Private Sector Public Sector Surveys and Questionnaires nan
1
Antiprotozoal Agents / pharmacology; Brazil; Colombia; French Guiana; Genetic Variation; Honduras; Humans; Insecticide Resistance / genetics; Mexico; Mutation; Nicaragua; Plasmodium vivax / enzymology; Plasmodium vivax / genetics; Pyrimethamine / pharmacology; South America; Tetrahydrofolate Dehydrogenase / genetics; Mexico; Nicaragua; Peru; Plasmodium vivax; polymorphism; pvdhfr; pyrimethamine.
1
Antropología Médica; Reforma de la Atención de Salud; Descentralización; Sistemas de Salud.
2
Antropometría; Constitución Corporal; Estándares de Referencia
1
Antropometría; Constitución corporal; Obesidad / Prevención,
1